About this information
Search the summaries of completed Access to Information (ATI) requests to find information about ATI requests made to the Government of Canada after January 2020. If you find a summary of interest, you can request a copy of the records at no cost using the form below each summary. Requests made through this form are considered informal requests and are not subject to the same requirements as requests under the Access to Information Act (ATIA).
If you don’t find what you are looking for you can request additional government records under an institution’s control by contacting the institution’s Access to Information and Privacy Coordinator or by submitting a formal access to information request.
*All information provided will incorporate the necessary exemptions and exclusions as per the Access to Information Act and the Privacy Act.
Download datasets of the summaries of completed access to information requests.
Current Search
Report Type
Organization
Disposition
Year
Month
Found 25 record(s)
Req # A-2021-001601
For the Abbreviated New Drug Submission underlying the generic submission under review containing the medicinal ingredient “trabectedin”, provide the “Batch Formula” (3.2.P.3.2).Organization: Health Canada
February 2022
Req # A-2021-001602
For the Abbreviated New Drug Submission underlying the generic submission under review containing the medicinal ingredient “trabectedin”, provide the “Description of Manufacturing Process and Process Controls” (3.2.P.3.3).Organization: Health Canada
February 2022
Req # A-2021-001605
For the Abbreviated New Drug Submission underlying the generic submission under review containing the medicinal ingredient “trabectedin”, provide the proposed Product Monograph.Organization: Health Canada
February 2022
Req # A-2021-051
Request concerning the recommendations issued by the Office of the Commissioner of Official Languages as part of an investigation into a complaint filed by a Francophone constable stationed in British Columbia in 2001 at the Richmond Detachment. The report was issued in April 2005, and the report reference number is 0600-2002-R2. The request for disclosure involves the five recommendations made by the Commissioner of Official Languages to the Royal Canadian Mounted Police.Organization: Office of the Commissioner of Official Languages
December 2021
Req # A-2021-003
“From January 1, 2011 to December 31, 2019, provide data or reports on the level of Code 699 usage prior to the pandemic; i.e. information showing the level of Code 699 usage in the federal public service, by department. Limit records to final version or last available draft. Exclude records that may require consult with DOJ to confirm possible cabinet confidences.”Organization: Office of the Commissioner of Official Languages
June 2021
Req # A-2020-046
"The agenda and minutes from the discussion group meeting between the Canadian Radio-television and Telecommunications Commission (CRTC) and the Official Language Minority Communities (OLMCs) held on November 30, 2011 ( OCOL reference file 2016-0699-EI (2013-0400), where the Commissionner issued two preliminary reports and one final investigation report)."Organization: Office of the Commissioner of Official Languages
March 2021
Req # A-2020-000953
The list of the number of registration certificates authorizing the production of Cannabis for personal possession and/or for medical use in the City of Saint-Colomban area.Organization: Health Canada
November 2020
Req # A-2020-000059
In relation to the Non-Insured Health Benefits Program (the “NIHB”), all final letters, memoranda, memoranda to Cabinet, briefing notes, strategic plans, data/analyses, reports/evaluations, opinions or agreements (including funding agreements),Organization: Health Canada
September 2020
Req # A-2019-001561
A record which indicates whether the 2 octreotide acetate submissions posted on the Generic Submissions Under Review (GSUR) listing pertain to a single manufacturer or not.Organization: Health Canada
March 2020
Req # A-2019-000740
All documents submitted by Sandoz Canada Inc. in Electronic Common Technical Document (eCTD) Module 1.6.1 (Comparative Bioavailability Information) of any Abbreviated New Drug Submissions made by Sandoz Canada Inc. for its GLATOPA product (glatiramer acetate).Organization: Health Canada
February 2020